对精神分裂症患者的卢马特佩龙数据的分析,使用来自FDA不良事件报告系统的相关不良事件
Shengzhu Sun1, Ying Zhang1, Hongyun Wu2
1First College of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, PR China.
Expert opinion on drug safety
|August 28, 2024
概括
这项研究使用FAERS数据分析了lumateperone不良事件. 关键发现包括意外事件,如灼热感和震,大多数不良事件发生在治疗的第一个月内.
科学领域:
- 药物监督 药物监督 药物监督
- 临床药理学 临床药理学
- 药品安全 药品安全
背景情况:
- 对第二代抗精神病药 Lumateperone 的不良事件 (AE) 信号的分析.
- 使用了美国食品和药物管理局的不良事件报告系统 (FAERS) 数据库.
- 专注于对精神分裂症治疗的临床安全监测.
研究的目的:
- 为了识别和描述与lumateperone相关的不良药物事件 (ADEs).
- 为临床安全监测提供全面的参考资料.
- 检测目前药品标签上没有列出的潜在安全信号.
主要方法:
- 使用国际医学术语词典 (26.0版本) 标准化的ADE数据.
- 采用了四种算法:报告赔率比率 (ROR),比例报告比率 (PRR),贝叶斯信任传播神经网络 (BCPNN) 和多项式玛-鱼收缩 (MGPS).
- 分析了来自FAERS的2542份病例报告,确定了1762人,其中卢马特佩龙是主要嫌疑人.
主要成果:
- 在26个系统器官类别 (SOC) 中确定了118个与甲相关的AE的显著不成比例的优先术语 (PT).
- 检测到意想不到的副作用,如灼热感,震和偏头痛.
- 副作用的发病时间中位数为9天,大多数发生在治疗的第一个月内.
结论:
- 这项研究增强了对lumateperone潜在不良事件的理解.
- 识别了超出现有药物说明书中的安全信号.
- 为lumateperone的临床使用和安全监测提供了宝贵的见解.
相关概念视频
Pharmacovigilance
795
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
795
Mania and Antimanic Drugs: Overview
155
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
155
Drug Therapy
40
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
40
Psychosis: Goals of Pharmacotherapy
114
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
114
Psychosis and Antipsychotic Drugs: Overview
207
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
207
Antidepressant Drugs: MAOIs and Other Agents
205
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
205


